Riskpilot← Back to searchSign inGet full accessBergus Health AB
ABActiveOrg 5568308414Linnégatan 7Other human health activities n.e.c. · NACE 8699Est. 20103 employees
Revenue 2024
SEK 6,5M
+179% vs 2023
EBITDA margin
13.9%
+149% vs 2023
Equity ratio
56.3%
Financial strength
Net profit 2024
SEK 1,8M
+101% vs 2023
| Revenue | SEK 6,5M | +179% |
| EBITDA | SEK 900K | +149% |
| Net profit | SEK 1,8M | +101% |
| Total assets | SEK 5M | +20% |
| Equity | SEK 2,8M | +48% |
| Employees | 3 | — |
Legal name
Bergus Health AB
Org number
5568308414
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
9 december 2010
Share capital
SEK 1 000 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska utföra personaladministrativa tjänster och företagshälsovård samt bedriva därmed förenlig verksamhet.
Address
Linnégatan 7
Phone
+46840027500
Email
info@bergus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 225 | 1 005 | 818 | 2 323 | 6 481 |
| Staff expenses | — | — | −523 | — | — |
| EBITDA | −79 | −532 | −971 | −1 854 | 900 |
| Depreciation & amort. | −141 | −171 | −61 | −35 | −35 |
| EBIT | −220 | −703 | −1 157 | −1 889 | 865 |
| Net financials | 793 | 3 005 | −59 | 2 796 | −1 |
| Profit before tax | 6 486 | 4 152 | 0 | 908 | 1 821 |
| Tax | −1 187 | −237 | −27 | −0 | −0 |
| Net profit | 5 299 | 3 915 | −27 | 908 | 1 821 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 13 711 | 9 149 | 3 642 | 4 171 | 5 008 |
| Equity | 6 299 | 4 915 | 1 000 | 1 908 | 2 821 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 5 562 | 1 925 | 2 642 | 2 263 | 2 187 |
| Total debt | 5 562 | 1 925 | 2 642 | 2 263 | 2 187 |
EBITDA margin
13.9%
This company
15.8%
Market median
-12% vs market
20202024
Equity ratio
56.3%
This company
38.2%
Market median
+47% vs market
20202024
Return on equity
64.6%
This company
18.4%
Market median
+251% vs market
20202024
Net profit margin
28.1%
This company
8.1%
Market median
+247% vs market
20202024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20202024
Debt / equity
0.78×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SM Chief Executive Officer | Chief Executive Officer | 2022 |
HM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bergus Holding AB
Bergus Health AB Board members of Bergus Health AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofie Margareta Imhagen | Chief Executive Officer | 0 companies |
| Hans Mikael Johansson | Audit | 0 companies |
| Karl Johan Bergling | Board of Directors | 0 companies |
| Karl Tomas Bergling | Chairman | 0 companies |